Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dental injection pain reduction with lidocaine/articaine buccal patches with or without dexmedetomidine
IRCT20210118050067N2Phase 2Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of lidocaine, articaine and dexmedetomidine in pain (6 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoint: Pain level during injection. Started Aug 2022; status: completed.
02
Drugs
lidocainearticainedexmedetomidine
03
Conditions
pain
Beyond the preview
Go deeper on IRCT20210118050067N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210118050067N2.